Mode
Text Size
Log in / Sign up

Hematology

108 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Network meta-analysis of vital pulp therapy success in mature permanent teeth with carious exposure
Hematology Meta-analysis
Network meta-analysis of vital pulp therapy success in mature permanent teeth with carious exposure New Study Reveals Which Fillings Actually Save Your Tooth
This network meta-analysis of 2906 teeth from 35 RCTs synthesized evidence on vital pulp therapy for carious pulp exposure in mature permane…
This major analysis shows that for saving a damaged tooth nerve, newer materials are more reliable than the old standard, giving patients a …
Case report and literature review of ENKTL presenting with ocular symptoms and treated with GemOx
Hematology Sys. Review
Case report and literature review of ENKTL presenting with ocular symptoms and treated with GemOx A Rare Eye Symptom Led Doctors Down the Wrong Path for Months
This case report and literature review describes a single patient with extranodal natural killer/T cell lymphoma presenting with ocular symp…
Double vision and sinus scans that looked clean hid a rare lymphoma that stole a man's sight after months of wrong treatments.
Review summarizes fenofibrate, metformin, and MSC modulation in Primary Sjögren disease management
Hematology Sys. Review
Review summarizes fenofibrate, metformin, and MSC modulation in Primary Sjögren disease management The Dry Mouth Disease Has an Immune Fix Researchers Didn't Expect
This review examines the potential of fenofibrate, metformin, and mesenchymal stem cells in Primary Sjögren disease management.
Three existing drugs may restore the immune balance broken in Sjögren's disease, a chronic condition that destroys saliva and tear glands.
Review of solitary plasmacytoma radiotherapy outcomes in Indian tertiary care
Hematology
Review of solitary plasmacytoma radiotherapy outcomes in Indian tertiary care Rare Bone Tumor Treatment Shows Long-Term Success with Radiotherapy
This retrospective audit review from a tertiary care center in eastern India summarizes outcomes for 46 patients with solitary plasmacytoma …
A new look at real-world patients shows radiation therapy can control this rare cancer for over nine years.
Observational study identifies PF4-dependent antibodies in ELISA-negative HIT patients via functional testing
Hematology
Observational study identifies PF4-dependent antibodies in ELISA-negative HIT patients via functional testing Could stopping blood thinners because of a false negative test actually harm you?
This observational research article with an animal component evaluates PF4-dependent platelet-activating antibodies in ELISA-negative patien…
Standard blood tests for a dangerous clotting disorder missed six patients, leading doctors to stop life-saving medicine and causing new clo…
AMH Levels in Pediatric Cancer Patients Before and After Treatment
Hematology Cohort
AMH Levels in Pediatric Cancer Patients Before and After Treatment Could a simple blood test tell you if cancer treatment will hurt your future fertility?
This prospective cohort study evaluated anti-mullerian hormone (AMH) levels in 74 girls with pediatric cancer.
A simple blood test measuring egg counts drops 79% after cancer treatment, offering early warning for young girls facing chemotherapy.
FDA Approves Rytelo (telomerase inhibitor oligonucleotide) for transfusion-dependent anemia in low- to intermediate-1 risk MDS
Hematology FDA Approval
FDA Approves Rytelo (telomerase inhibitor oligonucleotide) for transfusion-dependent anemia in low- to intermediate-1 risk MDS FDA approves new drug called Rytelo for certain blood disorder patients who need frequent transfusions
Rytelo is approved for adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) who have transfusion-dependent anemia…
FDA approves Rytelo to help adults with low-risk blood disorders who need frequent transfusions after other treatments fail.
Meta-analysis finds non-clotting factor therapies reduce bleeding in congenital hemophilia
Hematology Meta-analysis
Meta-analysis finds non-clotting factor therapies reduce bleeding in congenital hemophilia Can new therapies help people with hemophilia bleed less and live better?
This meta-analysis of 6 RCTs (397 participants) synthesizes evidence on non-clotting factor therapies for bleed prevention in congenital hem…
For people with hemophilia, frequent bleeding can disrupt daily life and cause pain.
Phase 2 trial tests single-dose IV iron isomaltoside in severe aortic stenosis with iron deficiency
Hematology Phase II
Phase 2 trial tests single-dose IV iron isomaltoside in severe aortic stenosis with iron deficiency Early study suggests iron treatment may help heart function in severe aortic stenosis patients
This Phase 2, double-blind, randomized, placebo-controlled trial tested a single intravenous dose of iron isomaltoside versus placebo in pat…
Treating iron deficiency may improve exercise capacity and reduce fatigue in people with severe aortic stenosis, according to early trial re…
Meta-analysis of HSCT with treosulfan in Ataxia Telangiectasia patients shows mixed survival outcomes and significant toxicities
Hematology Meta-analysis
Meta-analysis of HSCT with treosulfan in Ataxia Telangiectasia patients shows mixed survival outcomes and significant toxicities A Teen With a Rare Disease Beat Leukemia After a Risky Transplant
This systematic review and meta-analysis evaluated hematopoietic stem cell transplantation (HSCT) using treosulfan in 16 patients with Ataxi…
A 16-year-old with a rare genetic disease survived leukemia after a tailored stem cell transplant, offering new hope for others with this fr…
BR regimen shows survival outcomes in newly diagnosed Waldenstroms Macroglobulinemia patients
Hematology
BR regimen shows survival outcomes in newly diagnosed Waldenstroms Macroglobulinemia patients A Rare Blood Cancer With an 8-Year Survival: What Real-World Data Shows
This single-center retrospective analysis evaluated 89 newly diagnosed Waldenstroms Macroglobulinemia patients treated with the BR regimen.
New real-world data shows patients with the rare blood cancer Waldenstrom's macroglobulinemia live a median of over 8 years after diagnosis.
Biomarkers and clinical factors show statistical associations with sepsis-induced coagulopathy in 37,459 patients
Hematology Meta-analysis
Biomarkers and clinical factors show statistical associations with sepsis-induced coagulopathy in 37,459 patients Your Blood May Signal a Deadly Clotting Crisis Before It Strikes
This systematic review and meta-analysis evaluated 37,459 patients to assess the association between various biomarkers and clinical factors…
Blood markers like glycocalyx degradation and low fibrinogen can predict deadly clotting in sepsis patients early, potentially saving lives …